BDBM55432 4-[2-[[4-(2-furanyl)-2,6-dioxocyclohexylidene]methylamino]ethyl]-N-prop-2-enyl-1-piperazinecarbothioamide::4-[2-[[4-(furan-2-yl)-2,6-bis(oxidanylidene)cyclohexylidene]methylamino]ethyl]-N-prop-2-enyl-piperazine-1-carbothioamide::4-[2-[[4-(furan-2-yl)-2,6-dioxocyclohexylidene]methylamino]ethyl]-N-prop-2-enylpiperazine-1-carbothioamide::4-{2-[(4-Furan-2-yl-2,6-dioxo-cyclohexylidenemethyl)-amino]-ethyl}-piperazine-1-carbothioic acid allylamide::MLS000558830::N-allyl-4-[2-[[4-(2-furyl)-2,6-diketo-cyclohexylidene]methylamino]ethyl]piperazine-1-carbothioamide::SMR000149146::US11529321, Compound 39::cid_4637001
SMILES C=CCNC(=S)N1CCN(CCNC=C2C(=O)CC(CC2=O)c2ccco2)CC1
InChI Key InChIKey=DTMDHBQJFPMOSC-UHFFFAOYSA-N
Data 2 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 55432
Wigen Biomedicine Technology (Shanghai)
US Patent
